Spartan Fund Management’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-24,530
Closed -$302K 483
2022
Q1
$302K Buy
+24,530
New +$302K 0.05% 309